Brief: Aligos Therapeutics Strengthens Senior Leadership Team With The Appointment Of Hardean Achneck, MD As Chief Medical Officer
24/09/2024 13:44
Sept 24 (Reuters) - Aligos Therapeutics Inc ALGS.O :
* ALIGOS THERAPEUTICS STRENGTHENS SENIOR LEADERSHIP TEAM
WITH THE
APPOINTMENT OF HARDEAN ACHNECK, MD AS CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nGNX7qCLwZ
Further company coverage: ALGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices